The shorters have dominated the stock. Given covid affects it...

The shorters have dominated the stock. Given covid affects it probably did not matter and it will not take much solid good news for the share price to escalate from this dismal low . US analysts catastrophising China events, on any news, has not helped either . We will see strong growth next year as this company reorganizes, expands in the US, hopefully strengthens inroads in other Asian markets , strengthens China interests whether with china retail sales and business/ share ownership links . Neither the US or Australia have the generous Diary terms in their FTT's like NZ. Less reliance on Daigou will be better for the company, nobody in 2019 could have predicted the surreal affect of covid, and it served its purpose with allowing huge expansion of the company much needed to establish early front runner success given low competition barriers.